Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Stem Cell Transplant for Hemoglobinopathy
This study is currently recruiting participants.
Study NCT00176852 Information provided by Masonic Cancer Center, University of Minnesota
First Received: September 12, 2005 Last Updated: August 20, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Sickle Cell Disease
Thalassemia
Severe Congenital Neutropenia
Diamond-Blackfan Anemia
Shwachman-Diamond Syndrome
Additional conditions recognized in this trial
Anemia, Diamond-Blackfan
Anemia, Sickle Cell
Hemoglobinopathies
Neutropenia
Syndrome
More general conditions related to this trial
Agranulocytosis
Anemia
Anemia, Aplastic
Anemia, Hemolytic
Anemia, Hemolytic, Congenital
Anemia, Hypoplastic, Congenital
Bone Marrow Diseases
Disease
Genetic Diseases, Inborn
Hematologic Diseases
Leukocyte Disorders
Leukopenia
Pathologic Processes
Red-Cell Aplasia, Pure
Interventions listed in this trial
Busulfan, Fludarabine, ATG, TLI
Total Body Irradiation
Total Lymphoid Irradiation
Stem cell infusion
Additional drug interventions recognized in this trial
Alemtuzumab
Antilymphocyte Serum
Busulfan
Cyclophosphamide
Fludarabine
Fludarabine monophosphate
More general drug interventions related to this trial
Alkylating Agents
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antirheumatic Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Masonic Cancer Center, University of Minnesota
National Marrow Donor Program
Back to top of Main Content
